TB
Therapeutic Areas
Mindstate Design Labs Pipeline
| Drug | Indication | Phase |
|---|---|---|
| MSD-001 | Emotional & Cognitive Flexibility (Mental Health) | Phase 1 |
| MSD-X02 Series | Select Psychoactive Effects (CNS) | Preclinical |
| MSD-XXX Future Programs | Broad Psychoactive Effects (CNS) | Discovery |
Leadership Team at Mindstate Design Labs
DD
Dillan DiNardo
Co-Founder & CEO
TR
Thomas Ray, PhD
Scientific Co-Founder
RS
Rob Silva, PhD
Chief Scientific Officer